Cited by 475Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

Open access

Al-Sarraj, Safa, King, Andrew, Troakes, Claire, Smith, Bradley, Maekawa, Satomi, Bodi, Istvan, Rogelj, Boris, Al-Chalabi, Ammar, Hortobágyi, Tibor, Shaw, Christopher E.·2011·Acta Neuropathologica

DOI 10.1007/s00401-011-0911-2

Open this paper in CoChat — free account

Abstract

Neuronal cytoplasmic inclusions (NCIs) containing phosphorylated TDP-43 (p-TDP-43) are the pathological hallmarks of motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) and FTLD-TDP. The vast majority of NCIs in the brain and spinal cord also label for ubiquitin and p62, however, we have previously reported a subset of TDP-43 proteinopathy patients who have unusual and abundant p62 positive, TDP-43 negative inclusions in the cerebellum and hippocampus. Here we sought to determine whether these cases carry the hexanucleotide repeat expansion in C9orf72. Repeat primer PCR was performed in 36 MND/ALS, FTLD-MND/ALS and FTLD-TDP cases and four controls. Fourteen individuals with the repeat expansion were detected. In all the 14 expansion mutation cases there were abundant globular and star-shaped p62 positive NCIs in the pyramidal cell layer of the hippocampus, the vast majority of which were p-TDP-43 negative. p62 positive NCIs were also abundant in the cerebellar granular and molecular layers in all cases and in Purkinje cells in 12/14 cases but they were only positive for p-TDP-43 in the granular layer of one case. Abundant p62 positive, p-TDP-43 negative neuronal intranuclear inclusions (NIIs) were seen in 12/14 cases in the pyramidal cell layer of the hippocampus and in 6/14 cases in the cerebellar granular layer. This unusual combination of inclusions appears pathognomonic for C9orf72 repeat expansion positive MND/ALS and FTLD-TDP which we believe form a pathologically distinct subset of TDP-43 proteinopathies. Our results suggest that proteins other than TDP-43 are binding p62 and aggregating in response to the mutation which may play a mechanistic role in neurodegeneration.

Integrity signals

Registry

Crossref · 10.1007/s00401-011-0911-2

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Self-citation
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., et al. (2011) · Nature · doi:10.1038/nature10353 · Cited by 1,174
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012

Show all 35 references

Sorted by citations

Items 301–400 of 472

ALS Yeast Models—Past Success Stories and New Opportunities
Gregorio, S. E. D., & Duennwald, M. L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00394 · Cited by 27
C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?
Sellier, C., Corcia, P., Vourc’h, P., & Dupuis, L. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.03.008 · Cited by 24
Dystrophic neurites express C9orf72 in Alzheimer's disease brains
Satoh, J., Tabunoki, H., Ishida, T., Saito, Y., & Arima, K. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt136 · Cited by 21
Pure cerebellar ataxia linked to large C9orf72 repeat expansion
Corcia, P., Vourc’h, P., Guennoc, A., Amador, M. D. M., Blasco, H., Andres, C. R., Couratier, P., Gordon, P. H., & Meininger, V. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1113298 · Cited by 21
C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue
Scotter, E. L., Smyth, L. C. D., Bailey, J. W. T., Wong, C. H., de Majo, M., Vance, C. A., Synek, B. J., Turner, C. P., Pereira, J. A., Charleston, A., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.019 · Cited by 21
Self-citation
Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72 ‐ALS
Rifai, O. M., Longden, J., O’Shaughnessy, J., Sewell, M. D. E., Pate, J. A., McDade, K., Daniels, M. J. D., Abrahams, S., Chandran, S., McColl, B. W., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6008 · Cited by 20
Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease
Takeda, T., Seilhean, D., Ber, I. L., Millecamps, S., Sazdovitch, V., Kitagawa, K., Uchihara, T., & Duyckaerts, C. J. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx063 · Cited by 20
RANTing about C9orf72
Lashley, T., Hardy, J., & Isaacs, A. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.009 · Cited by 19
Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration
Hortobágyi, T., & Cairns, N. J. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00026-2 · Cited by 19
Self-citation
C9ORF72‐ALS: P62‐ and ubiquitin‐aggregation pathology in skeletal muscle
Türk, M., Haaker, G., Winter, L., Just, W., Nickel, F. T., Linker, R. A., Chevessier, F., & Schröder, R. (2014) · Muscle & Nerve · doi:10.1002/mus.24283 · Cited by 18
Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia
Antoniani, F., Cimino, M., Mediani, L., Vinet, J., Verde, E. M., Secco, V., Yamoah, A., Tripathi, P., Aronica, E., Cicardi, M. E., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01547-2 · Cited by 19
Novel Evidence of Phenotypical Variability in the Hexanucleotide Repeat Expansion in Chromosome 9
Cerami, C., Marcone, A., Galimberti, D., Zamboni, M., Fenoglio, C., Serpente, M., Scarpini, E. A., & Cappa, S. F. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122302 · Cited by 18
Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome
Sharaf, A. L., Mensching, L., Keller, C., Rading, S., Scheffold, M., Palkowitsch, L., Djogo, N., Rezgaoui, M., Kestler, H. A., Moepps, B., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00224 · Cited by 18
Characterization of an FTLD-PDB family with the coexistence of SQSTM1 mutation and hexanucleotide (G 4 C 2 ) repeat expansion in C9orf72 gene
Almeida, M. R., Letra, L., Pires, P., SANTOS, A. C. D. S., Rebelo, O., Guerreiro, R. J., van der Zee, J., Broeckhoven, C. V., & Santana, I. J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.015 · Cited by 18
C9orf72 poly-PR forms anisotropic condensates causative of nuclear TDP-43 pathology
Hodgson, R. E., Rayment, J. A., Huang, W.-P., Avila, A. S., Ellis, B. C. S., Lin, Y.-H., Soni, N., Hautbergue, G. M., & Shelkovnikova, T. A. (2024) · iScience · doi:10.1016/j.isci.2024.110937 · Cited by 17
Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin ( ANG ) mutation
Kirby, J., Highley, J. R., Cox, L. E., Goodall, G., Hewitt, C., Hartley, J. A., Hollinger, H. C., Fox, M., Ince, P. G., McDermott, C. J., et al. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12007 · Cited by 17
Als and Ftd: Insights into the disease mechanisms and therapeutic targets
Liščić, R. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.012 · Cited by 17
Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
Mayl, K., Shaw, C. E., & Lee, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9060601 · Cited by 18
Self-citation
Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations
Serpente, M., Fenoglio, C., Cioffi, S., Bonsi, R., Arighi, A., Fumagalli, G., Ghezzi, L., Scarpini, E. A., & Galimberti, D. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011385 · Cited by 18
Improved detection of RNA foci in C9orf72 amyotrophic lateral sclerosis post-mortem tissue using BaseScope™ shows a lack of association with cognitive dysfunction
Mehta, A. R., Selvaraj, B. T., Barton, S. K., McDade, K., Abrahams, S., Chandran, S., Smith, C., & Gregory, J. M. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa009 · Cited by 17
Implications of structural and functional brain changes in amyotrophic lateral sclerosis
Dharmadasa, T., Huynh, W., Tsugawa, J., Shimatani, Y., Ma, Y., & Kiernan, M. C. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1464912 · Cited by 16
ALS, a cellular whodunit on motor neuron degeneration
Karagiannis, P., & Inoue, H. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103524 · Cited by 16
FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
Leskelä, S., Hoffmann, D. B., Rostalski, H., Huber, N., Wittrahm, R., Hartikainen, P. H., Korhonen, V. E., Leinonen, V., Hiltunen, M. O., Solje, E., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02475-x · Cited by 16
Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair
Korsten, G., Osinga, M., Pelle, R. A., Serweta, A. K., Hoogenberg, B., Kampinga, H. H., & Kapitein, L. C. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202307142 · Cited by 16
A familial frontotemporal dementia associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Ferrari, R., Kero, M., Mok, K. Y., Paetau, A. E., Tienari, P. J., Tynninen, O., Hardy, J., Momeni, P., Verkkoniemi‐Ahola, A., & Myllykangas, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.021 · Cited by 15
Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis—a Systematic Review and Meta-Analysis of Preclinical Research
Elliott, E., Bailey, O., Waldron, F. M., Hardingham, G. E., Chandran, S., & Gregory, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00511 · Cited by 15
Modelling C9orf72-Related Amyotrophic Lateral Sclerosis in Zebrafish
Fortier, G., Butti, Z., & Patten, S. A. (2020) · Biomedicines · doi:10.3390/biomedicines8100440 · Cited by 15
Multiple system aging‐related tau astrogliopathy with complex proteinopathy in an oligosymptomatic octogenarian
Klotz, S., Fischer, P. A., Hinterberger, M., Ricken, G., Hönigschnabl, S., Gelpí, E., & Kovács, G. G. (2020) · Neuropathology · doi:10.1111/neup.12708 · Cited by 15
Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD — a Systematic Review and Meta-Analysis
Kaliszewska, A., Allison, J., Col, T.-T., Shaw, C. E., & Arias, N. (2021) · The Cerebellum · doi:10.1007/s12311-021-01320-0 · Cited by 15
Self-citation
Clinicopathological correlates in the frontotemporal lobar degeneration–motor neuron disease spectrum
Carbayo, Á., Borrego‐Écija, S., Turón‐Sans, J., Cortés‐Vicente, E., Molina‐Porcel, L., Gascón‐Bayarri, J., Rubio, M. Á., Povedano, M., Gámez, J., Sotoca, J., et al. (2024) · Brain · doi:10.1093/brain/awae011 · Cited by 15
TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia
Halliday, G. M., Kiernan, M. C., Kril, J. J., Mito, R., Masuda‐Suzukake, M., Hasegawa, M., McCann, H., Bartley, L., Dobson‐Stone, C., Kwok, J. B., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.005 · Cited by 14
Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion
Downey, L. E., Mahoney, C., Rossor, M. N., Crutch, S. J., & Warren, J. D. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt145 · Cited by 14
The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
Gelpí, E., Rahimi, J., Klotz, S., Schmid, S., Ricken, G., Forcen‐Vega, S., Budka, H., & Kovács, G. G. (2020) · Neuropathology · doi:10.1111/neup.12660 · Cited by 14
HnRNP Pathologies in Frontotemporal Lobar Degeneration
Jiang, X., Gatt, A. P., & Lashley, T. (2023) · Cells · doi:10.3390/cells12121633 · Cited by 13
Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia
Thumbadoo, K. M., Dieriks, B. V., Murray, H. C., Swanson, M. E. V., Yoo, J. H., Mehrabi, N. F., Turner, C. P., Dragunow, M., Faull, R. L. M., Curtis, M. A., et al. (2024) · Brain · doi:10.1093/brain/awae140 · Cited by 13
Self-citation
Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
Rossi, S., & Cozzolino, M. (2021) · Cells · doi:10.3390/cells10113005 · Cited by 15
C9ORF72, the new gene on the block, causes C9FTD/ALS: new insights provided by neuropathology
Bigio, E. H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0919-7 · Cited by 13
The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Houghton, O. H., Mizielinska, S., & Gómez‐Suaga, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.838402 · Cited by 12
Reversal of C9orf72 mutation-induced transcriptional dysregulation and pathology in cultured human neurons by allele-specific excision
Sachdev, A., Gill, K., Sckaff, M., Birk, A. M., Arogundade, O. A., Brown, K. A., Chouhan, R. S., Issagholian-Lewin, P. O., Patel, E. M., Watry, H. L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307814121 · Cited by 12
Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog
Langseth, A. J., Kim, J., Ugolino, J., Shah, Y., Hwang, H., Wang, J., Bergles, D. E., & Brown, S. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-05864-2 · Cited by 13
Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient
Lamas, N. J., & Roybon, L. (2021) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2021.773424 · Cited by 12
Retinal vessels as a window on amyotrophic lateral sclerosis pathophysiology: A systematic review
Vautier, A., Lebreton, A., Codron, P., Awada, Z., Gohier, P., & Cassereau, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.11.010 · Cited by 12
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
Tan, R. H., McCann, H., Shepherd, C. E., Pinkerton, M., Mazumder, S., Devenney, E. M., Adler, G. L., Rowe, D. B., Kril, J. J., Halliday, G. M., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01670-2 · Cited by 12
C9ORF72 repeat expansion is not a significant cause of late onset cerebellar ataxia syndrome
Hsiao, C.-T., Tsai, P., Liao, Y., Lee, Y., & Soong, B. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.10.042 · Cited by 12
Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate‐length CAG repeat expansions in Ataxin‐2 does not have 1 C 2‐positive polyglutamine inclusions
Highley, J. R., Lorente-Pons, A., Cooper‐Knock, J., Wharton, S. B., Ince, P. G., Shaw, P. J., Wood, J. D., & Kirby, J. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12254 · Cited by 12
Multifaceted role of SMCR8 as autophagy regulator
Jung, J., & Behrends, C. (2017) · Small GTPases · doi:10.1080/21541248.2017.1346553 · Cited by 13
C9ORF72 repeat‐associated non‐ ATG ‐translated polypeptides are distributed independently of TDP ‐43 in a J apanese patient with c9 ALS
Konno, T., Tada, M., Shiga, A., Tsujino, A., Eguchi, H., Masuda‐Suzukake, M., Hasegawa, M., Nishizawa, M., Onodera, O., Kakita, A., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12157 · Cited by 11
Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer’s disease
Davidson, Y. S., Robinson, A., Snowden, J. S., & Mann, D. M. A. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-50 · Cited by 11
Simulated surgical-type cerebral biopsies from post-mortem brains allows accurate neuropathological diagnoses in the majority of neurodegenerative disease groups
King, A., Maekawa, S., Bódi, I., Troakes, C., Curran, O. E., Ashkan, K., & Al‐Sarraj, S. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-53 · Cited by 12
Self-citation
Treatment implications of C9ORF72
Sha, S. J., & Boxer, A. L. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt149 · Cited by 11
Modeling C9orf72-Related Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Drosophila
Sharpe, J. L., Harper, N. S., Garner, D. R., & West, R. J. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.770937 · Cited by 14
Motoneuron Disease
Sendtner, M. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_15 · Cited by 11
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9orf72 disease
Jambeau, M., Meyer, K. D., Hruška-Plocháň, M., Tabet, R., Lee, C.-Z., Ray-Soni, A., Aguilar, C., Savage, K., Mishra, N., Cavegn, N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123487119 · Cited by 12
Novel preparation of fungal conidiophores biomass as adsorbent for removal of phosphorus from aqueous solution
Kalaimurugan, D., Durairaj, K., Kumar, A. J., Senthilkumar, P., & Venkatesan, S. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-08307-0 · Cited by 11
Cell-Clearing Systems Bridging Repeat Expansion Proteotoxicity and Neuromuscular Junction Alterations in ALS and SBMA
Limanaqi, F., Busceti, C. L., Biagioni, F., Cantini, F., Lenzi, P., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114021 · Cited by 11
SFPQ regulates the accumulation of RNA foci and dipeptide repeat proteins from the expanded repeat mutation in C9orf72
Malnar, M., & Rogelj, B. (2021) · Journal of Cell Science · doi:10.1242/jcs.256602 · Cited by 12
Self-citation
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 11
Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in C9orf72 and C9orf72-Negative Patients
Christidi, F., Kleinerová, J., Tan, E. L., Delaney, S., Tacheva, A., Hengeveld, J. C., Doherty, M. A., McLaughlin, R. L., Hardiman, O. M., Siah, W. F., et al. (2024) · Biology · doi:10.3390/biology13070504 · Cited by 10
Oligonucleotide-Based Therapy for FTD/ALS Caused by theC9orf72Repeat Expansion: A Perspective
Fernandes, S., Douglas, A. G. L., Varela, M. A., Wood, M. J. A., & Aoki, Y. (2013) · Journal of Nucleic Acids · doi:10.1155/2013/208245 · Cited by 13
Targeting mitochondrial Ca2+ uptake for the treatment of amyotrophic lateral sclerosis
Zhong, R., Rua, M. T., & Wei‐LaPierre, L. (2023) · The Journal of Physiology · doi:10.1113/jp284143 · Cited by 12
Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion
Udine, E., DeJesus‐Hernandez, M., Tian, S., das Neves, S. P., Crook, R., Finch, N. A., Baker, M., Pottier, C. P., Graff‐Radford, N. R., Boeve, B. F., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02720-2 · Cited by 11
Molecular Mechanisms of Amyotrophic Lateral Sclerosis
Collins, M. A., & Bowser, R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00004-3 · Cited by 10
Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Hao, Z., Wang, R., Ren, H., & Wang, G. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00567-7 · Cited by 11
ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stress
McLean, J. R., Smith, G. A., Rocha, E. M., Osborn, T. M., Dib, S., Hayes, M. A., Beagan, J. A., Brown, T. B., Lawson, T., Hallett, P. J., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.024 · Cited by 10
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Hortobágyi, T., & Cairns, N. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.012 · Cited by 10
Self-citation
Potential multisystem degeneration in Asidan patients
Ohta, Y., Yamashita, T., Hishikawa, N., Sato, K., Matsuzono, K., Tsunoda, K., Hatanaka, N., Takemoto, M., Takemi, T., Takamatsu, K., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.003 · Cited by 10
Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases
Trejo‐Lopez, J. A., Sorrentino, Z. A., Riffe, C. J., Prokop, S., Dickson, D. W., Yachnis, A. T., & Giasson, B. I. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa007 · Cited by 12
Histone deacetylases ( HDACs ) in frontotemporal lobar degeneration
Whitehouse, A., Doherty, K. S. G., Yeh, H. H., Robinson, A., Rollinson, S. J., Pickering-Brown, S. M., Snowden, J. S., Thompson, J. C., Davidson, Y. S., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12153 · Cited by 11
Molecular Genetics of Frontotemporal Dementia
Ferrari, R., Thumma, A., & Momeni, P. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0024457 · Cited by 11
DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD
Fu, X., Zhang, Z., Hayes, L. R., Wright, N., Asbury, J., Li, S., Ye, Y., & Sun, S. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114768 · Cited by 9
Bioinformatics Data Mining Approach Suggests Coexpression of AGTPBP1 with an ALS-linked Gene C9orf72
Kitano, S., Kino, Y., Yamamoto, Y., Takitani, M., Miyoshi, J., Ishida, T., Saito, Y., Arima, K., & Satoh, J. (2015) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s24317 · Cited by 10
Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion
Suárez‐Calvet, M., Camacho, V., Gómez‐Ansón, B., Antón‐Aguirre, S., Vives‐Gilabert, Y., Dols‐Icardo, O., Clarimón, J., Alcolea, D. A., Blesa, R., Fortea, J., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000056 · Cited by 9
Frontotemporal dementia
Perry, D. C., & Rosen, H. J. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch5 · Cited by 9
SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron
Mitsui, S., Otomo, A., Sato, K., Ishiyama, M., Shimakura, K., Okada-Yamaguchi, C., Warabi, E., Yanagawa, T., Aoki, M., Shang, H., et al. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105364 · Cited by 8
Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion
Ber, I. L. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.04.004 · Cited by 8
Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis
Noches, V., Campos‐Melo, D., Droppelmann, C. A., & Strong, M. J. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1417961 · Cited by 8
Immiscible inclusion bodies formed by polyglutamine and poly(glycine-alanine) are enriched with distinct proteomes but converge in proteins that are risk factors for disease and involved in protein degradation
Radwan, M., Lilley, J. D., Ang, C., Reid, G. E., & Hatters, D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233247 · Cited by 8
Genetic and Molecular Aspects of Frontotemporal Lobar Degeneration
Haapasalo, A., & Remes, A. M. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0063-5 · Cited by 9
Frontotemporal lobar degeneration: Diversity of FTLD lesions
Seilhean, D., Bielle, F., Plu, I., & Duyckaerts, C. J. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.015 · Cited by 9
Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle
Mihevc, S. P., Pavlin, M., Darovic, S., Živin, M., Podbregar, M., Rogelj, B., & Marš, T. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0940-y · Cited by 8
Self-citation
C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
Zubizarreta, I. K., Manero-Azua, Á., Afonso-Agüera, J., & de Nanclares, G. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091396 · Cited by 8
Molecular basis of ALS and FTD: implications for translational studies / Molekularna osnova ALS-a i FTD-a: implikacije za translacijska istraživanja
Liščić, R. M. (2015) · Archives of Industrial Hygiene and Toxicology · doi:10.1515/aiht-2015-66-2679 · Cited by 7
Speech and Language Presentations of FTLD-TDP Type B Neuropathology
Lee, D. J., Bigio, E. H., Rogalski, E. J., & Mesulam, M. M. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz132 · Cited by 7
Atypical TDP ‐43 protein expression in an ALS pedigree carrying a p. Y374X truncation mutation inTARDBP
Cooper‐Knock, J., Julian, T. H., Feneberg, E., Highley, J. R., Sidra, M., Turner, M. R., Talbot, K., Ansorge, O., Allen, S. P., Moll, T., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13104 · Cited by 7
Demencia por déficit de vitamina B12: Caso clínico
Behrens, M. I., Violeta Díaz, T., Vásquez, C., V, & Archibaldo Donoso, S. (2003) · Revista médica de Chile · doi:10.4067/s0034-98872003000800012 · Cited by 7
Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series
Feng, C., Chen, Q., Luan, X., Sun, P., Cao, Y., Wu, J., Wang, S., Sun, X., Cao, L. H., & Tian, G. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1188193 · Cited by 6
Model Systems of Motor Neuron Diseases As a Platform for Studying Pathogenic Mechanisms and Searching for Therapeutic Agents
Valetdinova, K. R., Medvedev, S. P., & Zakian, S. M. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-1-19-36 · Cited by 6
Aspects of degradation and translation of the expanded C9orf72 hexanucleotide repeat RNA
Mori, K., Gotoh, S., & Ikeda, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15847 · Cited by 6
Autophagy-Lysosome Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
Sullivan, P. M., Zhou, X., & Hu, F. (2017) · InTech eBooks · doi:10.5772/intechopen.69371 · Cited by 6
Lysosomal escape and TMEM106B fibrillar core determine TDP-43 seeding outcomesPreprint
Zhong, W., Scialò, C., Gatta, B., Haefliger, M. A., Leu, N., Lurati, F., Peter, M., Ramesh, N., Roschitzki, B., Jagannath, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.695531 · Cited by 7
Proteinopathies associated to repeat expansion disorders
Fourier, A., & Quadrio, I. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02454-5 · Cited by 6
Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
Koga, S., Murakami, A., Soto‐Beasley, A. I., Walton, R. L., Baker, M., Castanedes‐Casey, M., Josephs, K. A., Ross, O. A., & Dickson, D. W. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01611-z · Cited by 5
C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia
Bhatt, N. N., Puangmalai, N., Sengupta, U., Jerez, C., Kidd, M., Gandhi, S. S., & Kayed, R. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105628 · Cited by 5
BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
Rostalski, H., Hietanen, T., Leskelä, S., Beháňová, A., Abdollahzadeh, A., Wittrahm, R., Mäkinen, P. M., Huber, N., Hoffmann, D. B., Solje, E., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.550140 · Cited by 5
Neurodegenerative Diseases and RNA-Mediated Toxicity
Todd, T. W., & Petrucelli, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00015-8 · Cited by 5
Multiple Neuropathologies Underly Hippocampal Subfield Atrophy in a Case With a Slowly Progressive Amnestic Syndrome: Challenging the Notion of Pure LATE ‐ NC
Youssef, H., Gatto, R. G., Pham, N. T. T., Jones, D. T., Petersen, R. C., Machulda, M. M., Whitwell, J. L., & Josephs, K. A. (2025) · Neuropathology · doi:10.1111/neup.70000 · Cited by 4
Saccharomyces cerevisiae as a Model for Studying Human Neurodegenerative Disorders: Viral Capsid Protein Expression
Bayandina, S. V., & Mukha, D. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417213 · Cited by 7
Animal Models and Experimental Research in Medicine
Karapehlivan, M., Gelen, V., & Kükürt, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100993 · Cited by 4
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity
Morón-Oset, J., Fischer, L. K., Jauré, N., Zhang, P., Jahn, A. J., Supèr, T., Pahl, A., Isaacs, A. M., Grönke, S., & Partridge, L. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01634-6 · Cited by 5
Genetics of Amyotrophic Lateral Sclerosis
Kenna, K. P., Landers, J. E., & Ticozzi, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00003-1 · Cited by 4

Authors: Al-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Hortobágyi, T., & Shaw, C. E.
Affiliations: King's College London (GB)
Corresponding author: King, Andrew
ORCID: King, Andrew
Troakes, Claire
Smith, Bradley
Rogelj, Boris
Hortobágyi, Tibor
Shaw, Christopher E.
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2011-11-19
Volume: 122
Issue: 6
Pages: 691-702
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-011-0911-2
OpenAlex: W2066002405
Cited by: 475
References: 35
Citations by year: 2026: 9 · 2025: 9 · 2024: 22 · 2023: 24 · 2022: 23 · 2021: 23 · 2020: 40 · 2019: 27 · 2018: 24 · 2017: 39 · 2016: 38 · 2015: 41 · 2014: 42 · 2013: 63 · 2012: 45
FWCI: 31.22
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
Research Portal (King's College London) (submittedVersion)
Funders: Wellcome Trust (089701)
Medical Research Council (MC_G1000733)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: p62, TDP-43, C9orf72, hexanucleotide repeat expansion, amyotrophic lateral sclerosis, motor neuron disease, frontotemporal lobar degeneration, FTLD-TDP, neuronal cytoplasmic inclusions, neuronal intranuclear inclusions, cerebellum, hippocampus, Purkinje cells, neurodegeneration, protein aggregation
MeSH terms: Sequestosome-1 Protein, C9orf72 Protein, Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Inclusion Bodies, Cerebellum, DNA, DNA-Binding Proteins, Female, Hippocampus, Humans, Male, Middle Aged, Mutation, Neurons, Proteins, Purkinje Cells, Case-Control Studies, Pyramidal Cells, DNA Repeat Expansion, Intranuclear Inclusion Bodies, Adaptor Proteins, Signal Transducing, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks